Confronto fra l’Attività di Isepamicina, un Nuovo Aminoglicoside, e di Altri Antibiotici su Patogeni Nosocomiali Recentemente Isolati in Italia
Explore this paper's citation graph
Summary
Given its broad spectrum of bactericidal activity and its ability to overcome amikacin resistance, especially in Enterobacteriaceae, isepamicin represents a potentially useful drug in the empirical therapy of severe nosocomial infections.
- Type
- article
- Published
- 1996-12-01
- Cited by
- 0
- References
- 15
- OpenAlex
- https://openalex.org/W1989454246
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:71415638
Keywords
Amikacin, Aminoglycoside, Imipenem, Ciprofloxacin, Ceftazidime
References
- Susceptibility of respiratory strains of Staphylococcus aureus to fifteen antibiotics: results of a collaborative surveillance study (1992-1993). The Alexander Project Collaborative Group.
- National Committee for Clinical Laboratory Standards.
- Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.
- In-vitro susceptibilities of gram-positive bacteria to cefpirome, vancomycin, isepamicin and gentamicin, singly and in combination.
- The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.
- Inactivation of antibiotics and the dissemination of resistance genes.
- Trends in the epidemiology and antibiotic resistance of clinical Staphylococcus strains in Italy--a review.
- Lower Respiratory Tract Infections in the Intensive Care Unit: Consequences of Antibiotic Resistance for Choice of Antibiotic
- Antimicrobial agent therapy for Pseudomonas aeruginosa
- Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin
- An overview of nosocomial infections, including the role of the microbiology laboratory
- Pharmacokinetics of intravenously administered isepamicin in men
- Antibiotic resistance of clinical isolates of Enterococcus in Italy.
- Antibiotic susceptibility testing by a standardized single disk method.
- Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli and enterococci.
Cited by
No citing papers recorded for this paper.
Related papers
- Antibacterial activity of achievable epithelial lining fluid exposures of Amikacin Inhale with or without meropenem.
- Postantibiotic Effect of a Combination of Antimicrobial Agents on Pseudomonas aeruginosa
- Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group.
- Killing activity of meropenem in combination with amikacin against VIM- or KPC-producing Enterobacteriaceae that are susceptible, intermediate, or resistant to amikacin.
- Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa
- Nephrotoxicity of Aminoglycosides in Young and Adult Rats
- Efficacy of Combination of Meropenem with Gentamicin, and Amikacin against Resistant E. coli Isolated from Patients with UTIs: in vitro Study
- Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen.
- Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis
- [Comparative study of meropenem and amikacin/metronidazole combination in the treatment of severe abdominal surgical infections].